Dimensional Fund Advisors LP Purchases 71,258 Shares of CME Group Inc. $CME

Dimensional Fund Advisors LP grew its position in CME Group Inc. (NASDAQ:CME) by 6.5% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 1,167,693 shares of the financial services provider’s stock after purchasing an additional 71,258 shares during the period. Dimensional Fund Advisors LP owned about 0.32% of CME Group worth $315,520,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. First Horizon Advisors Inc. raised its stake in CME Group by 0.7% during the 2nd quarter. First Horizon Advisors Inc. now owns 5,269 shares of the financial services provider’s stock worth $1,453,000 after buying an additional 36 shares during the period. MBM Wealth Consultants LLC raised its position in shares of CME Group by 2.7% during the second quarter. MBM Wealth Consultants LLC now owns 1,422 shares of the financial services provider’s stock worth $392,000 after purchasing an additional 37 shares during the period. West Family Investments Inc. lifted its holdings in shares of CME Group by 1.2% during the 3rd quarter. West Family Investments Inc. now owns 3,062 shares of the financial services provider’s stock valued at $827,000 after purchasing an additional 37 shares in the last quarter. Atlatl Advisers LLC grew its position in shares of CME Group by 1.8% in the 3rd quarter. Atlatl Advisers LLC now owns 2,126 shares of the financial services provider’s stock valued at $574,000 after purchasing an additional 38 shares during the period. Finally, Verus Capital Partners LLC grew its position in shares of CME Group by 0.6% in the 3rd quarter. Verus Capital Partners LLC now owns 7,025 shares of the financial services provider’s stock valued at $1,898,000 after purchasing an additional 40 shares during the period. Institutional investors and hedge funds own 87.75% of the company’s stock.

Insider Buying and Selling at CME Group

In other CME Group news, CEO Terrence A. Duffy sold 25,000 shares of the company’s stock in a transaction on Thursday, December 11th. The shares were sold at an average price of $269.55, for a total transaction of $6,738,750.00. Following the sale, the chief executive officer directly owned 65,804 shares of the company’s stock, valued at approximately $17,737,468.20. This represents a 27.53% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Dennis Suskind sold 748 shares of CME Group stock in a transaction dated Friday, February 6th. The shares were sold at an average price of $300.00, for a total transaction of $224,400.00. Following the completion of the transaction, the director directly owned 2,699 shares of the company’s stock, valued at approximately $809,700. This trade represents a 21.70% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 30,248 shares of company stock valued at $8,355,450 in the last 90 days. Company insiders own 0.30% of the company’s stock.

Wall Street Analysts Forecast Growth

CME has been the topic of several research analyst reports. JPMorgan Chase & Co. raised their target price on shares of CME Group from $262.00 to $266.00 and gave the stock an “underweight” rating in a report on Thursday, February 5th. Jefferies Financial Group upped their target price on shares of CME Group from $302.00 to $356.00 and gave the stock a “buy” rating in a research note on Monday. Weiss Ratings raised CME Group from a “buy (b+)” rating to a “buy (a-)” rating in a research note on Monday. Piper Sandler upped their price objective on CME Group from $296.00 to $313.00 and gave the stock an “overweight” rating in a research report on Thursday, November 13th. Finally, Barclays increased their price objective on CME Group from $304.00 to $312.00 and gave the stock an “equal weight” rating in a report on Thursday, February 5th. One investment analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, seven have assigned a Hold rating and three have assigned a Sell rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $302.71.

CME Group News Summary

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: Jefferies raised its price target on CME to $356, an analyst upgrade that supports a higher valuation and likely contributed to recent buying and the stock reaching a new 1‑year high. Analyst upward revisions can lend momentum and justify higher multiples for CME. Jefferies Boosts CME Price Target
• Positive Sentiment: CME also hit a new one‑year high following that analyst upgrade, signaling strong near‑term demand and positive sentiment among investors. That price peak may have increased visibility and trading in the shares. CME Hits New 1‑Year High
• Neutral Sentiment: Argus reiterated a “hold” rating on CME, a neutral endorsement that neither materially changes the sell‑side narrative nor provides a clear catalyst for price movement. Argus Hold Reaffirmed
• Neutral Sentiment: Crypto market commentary points to a potential Bitcoin move toward $80k and references an unfilled CME gap; if realized, stronger crypto prices could lift CME’s crypto‑futures volumes, but this outcome is uncertain and timing is unclear. Investors should view this as a possible upside to derivatives volumes rather than a guaranteed driver. Bitcoin Signals $80K Target
• Neutral Sentiment: Short‑interest data published for early March shows anomalous values (reported as 0 shares and NaN increases). The figures appear erroneous or incomplete, so they should not be treated as evidence of increased bearish positioning until corrected data is released. (No reliable source link available in the entry.)

CME Group Price Performance

NASDAQ:CME opened at $316.81 on Friday. CME Group Inc. has a 52-week low of $248.53 and a 52-week high of $329.16. The company has a market cap of $114.24 billion, a P/E ratio of 28.39, a P/E/G ratio of 3.72 and a beta of 0.24. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.03 and a current ratio of 1.03. The stock’s 50-day simple moving average is $291.37 and its 200 day simple moving average is $277.29.

CME Group (NASDAQ:CME) last issued its quarterly earnings results on Wednesday, February 4th. The financial services provider reported $2.77 EPS for the quarter, beating the consensus estimate of $2.75 by $0.02. The firm had revenue of $1.65 billion during the quarter, compared to analysts’ expectations of $1.64 billion. CME Group had a return on equity of 14.65% and a net margin of 62.45%.The business’s quarterly revenue was up 8.1% compared to the same quarter last year. During the same period in the prior year, the firm posted $2.52 earnings per share. As a group, sell-side analysts forecast that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, March 26th. Investors of record on Tuesday, March 10th will be paid a $1.30 dividend. This is a boost from CME Group’s previous quarterly dividend of $1.25. This represents a $5.20 annualized dividend and a dividend yield of 1.6%. The ex-dividend date of this dividend is Tuesday, March 10th. CME Group’s dividend payout ratio (DPR) is 44.80%.

CME Group Company Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.